| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2002 | CN1367702A Renal cell carcinoma treatment |
| 09/04/2002 | CN1367701A Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2002 | CN1367699A Composition containing extracts of butyrospermum parkii and use as medicament or dietary supplement |
| 09/04/2002 | CN1367698A Administration of non-oral androgenic steroids to women |
| 09/04/2002 | CN1367697A Therapeutical method for improving cognition |
| 09/04/2002 | CN1367696A Method of enhancing insulin action |
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367694A Camptothecin analogs and methods of preparation thereof |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367692A Nicotine delivery systems |
| 09/04/2002 | CN1367691A New use of taxoid derivatives |
| 09/04/2002 | CN1367690A Combination therapy using pentafluorobenzenesulfonamide |
| 09/04/2002 | CN1367689A Utilisation of inhibitors of sodium hydrogen exchanger for producing medicament for preventing organ dysfunctions and diseases related to particular age and for prolonging life |
| 09/04/2002 | CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft |
| 09/04/2002 | CN1367687A Calcilytic compounds |
| 09/04/2002 | CN1367686A Novel compositions |
| 09/04/2002 | CN1367684A Method and composition for treating solid tumors |
| 09/04/2002 | CN1367683A Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 09/04/2002 | CN1367682A Drug delivery device, especially for delivery of androgens |
| 09/04/2002 | CN1367678A Method of treating hair loss using ketoamides |
| 09/04/2002 | CN1367653A Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 09/04/2002 | CN1367646A Ectoparasiticidal aqueous suspension formulations of Spinosyn |
| 09/04/2002 | CN1367256A 2-demethyl 2-methoxy-hygrolidin, its preparation method and medicine composition using said compound as active effective component |
| 09/04/2002 | CN1367189A Method for modifying polylacticacid by adopting unsaturated cyclic anhydride or unsaturated cyclic imide, modified product and application |
| 09/04/2002 | CN1367179A Novel liver regeneration related protein, its code sequence and application |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/04/2002 | CN1367167A Method for preparing carotenoid emulsion |
| 09/04/2002 | CN1367016A Compound preparation for curing diarrhea |
| 09/04/2002 | CN1366999A Guzhifengshi liquor for curing osteopathy and rheumatism |
| 09/04/2002 | CN1366997A Liquid medicine for curing beriberi |
| 09/04/2002 | CN1366991A Application of plant extract for preparing medicine to cure bone absorption increment diseases |
| 09/04/2002 | CN1366883A Chitin lozenge and its preparation method |
| 09/04/2002 | CN1366882A Medicine composition for effctive curing acne |
| 09/04/2002 | CN1366881A Method for curing some cancers by using estrogenic excitomotor and agonist |
| 09/04/2002 | CN1366880A Sophorcarpidine alkaloid and decongestant compound medicine and its preparation method |
| 09/04/2002 | CN1366879A Inhibiting free radical compound resulting in cancer cell transfer |
| 09/04/2002 | CN1366878A Texture screening granules containing active components |
| 09/04/2002 | CN1366874A Personal nursing compound |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090188C Benzonaphthyrindines compound |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090185C Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate thereof |
| 09/04/2002 | CN1090184C Heterocyclic compounds and preparing method thereof |
| 09/04/2002 | CN1090178C Tricyclic compounds having activity specific for integrins, particularly alpha V beta 3 integrins, method for preparing same |
| 09/04/2002 | CN1090177C Preparation of aromatic nitriles |
| 09/04/2002 | CN1090031C Novel use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 09/04/2002 | CN1090030C Complex cow's milk gamma globulin and making method thereof |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 09/04/2002 | CN1090028C Medicine for treatment of restenosis and arteriosclerosis |
| 09/04/2002 | CN1090027C Immunity-strengthening and infection-preventing medicine |
| 09/04/2002 | CN1090022C Cancer treatment by photodynamic therapy, in combination with immunoadjuvant |
| 09/04/2002 | CN1090021C Preparation method and use of sulfated oligosaccharides |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/04/2002 | CN1090018C Extended release formulation |
| 09/04/2002 | CN1090017C Controlled release formulation for water soluble drugs in which passageway is formed in situ |
| 09/03/2002 | USRE37828 Treatment and prevention of adhesions |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444859 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 09/03/2002 | US6444832 Osteoporosis |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents |
| 09/03/2002 | US6444824 Antiserotonine agents; side effect reduction |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444821 Humidity-controlling the crystals of n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-piperidino)ethyl)-1-formyl-4 -piperidinecarboxamide hydrochloride anhydride |
| 09/03/2002 | US6444820 Process for the manufacture of camptothecin derivatives |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444812 Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444810 Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions using an agent that minimizes amount of disulfides |
| 09/03/2002 | US6444809 Antihistamines |
| 09/03/2002 | US6444806 Complexing |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444795 Anticancer agents |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444709 Skin disorders; antiinflammatory agents; antiarthritic agents; cardiovascular disorders |
| 09/03/2002 | US6444708 Treatment using venlafaxine |
| 09/03/2002 | US6444707 Aqueous solutions; mixture of quaternary ammonium compound, surfactant and acid |
| 09/03/2002 | US6444706 Guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/03/2002 | US6444705 Angiogenesis inhibitors |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444703 4-(4-(4-methylbenzyloxycarbonyl) phanyl)phenyl trans-4-guanidinomethylcyclohexanecarboxylate or acid addition salt thereof and cyclodextrin; use treating ulcers for example |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/03/2002 | US6444700 Nutrient mixture of vitamin c and e, beta-carotene, selenium and glyceride |
| 09/03/2002 | US6444699 Method for treatment of aging or damage skin |
| 09/03/2002 | US6444698 Uniformity; forming barrier layer |
| 09/03/2002 | US6444697 Synthetic compounds for treatment of inflammation |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444695 Administering creatine; preovercoating prosthetics |
| 09/03/2002 | US6444694 Styryl benzimidazole derivatives |
| 09/03/2002 | US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof |
| 09/03/2002 | US6444689 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 09/03/2002 | US6444688 Compounds and compositions with nitrogen-containing non-basic side chains |
| 09/03/2002 | US6444687 Eating disorders and diabetes |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |